Form 8-K - Current report:
SEC Accession No. 0001837607-25-000055
Filing Date
2025-05-20
Accepted
2025-05-20 16:04:52
Documents
28
Period of Report
2025-05-20
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aeon-20250520x8k.htm   iXBRL 8-K 42215
2 EX-99 aeon-20250520xex99.htm EX-99 29452
3 GRAPHIC aeon-20250520xex99g001.jpg GRAPHIC 72502
4 GRAPHIC aeon-20250520xex99g002.jpg GRAPHIC 351534
5 GRAPHIC aeon-20250520xex99g003.jpg GRAPHIC 140030
6 GRAPHIC aeon-20250520xex99g004.jpg GRAPHIC 159376
7 GRAPHIC aeon-20250520xex99g005.jpg GRAPHIC 181547
8 GRAPHIC aeon-20250520xex99g006.jpg GRAPHIC 160649
9 GRAPHIC aeon-20250520xex99g007.jpg GRAPHIC 166987
10 GRAPHIC aeon-20250520xex99g008.jpg GRAPHIC 173636
11 GRAPHIC aeon-20250520xex99g009.jpg GRAPHIC 132891
12 GRAPHIC aeon-20250520xex99g010.jpg GRAPHIC 124590
13 GRAPHIC aeon-20250520xex99g011.jpg GRAPHIC 153007
14 GRAPHIC aeon-20250520xex99g012.jpg GRAPHIC 128247
15 GRAPHIC aeon-20250520xex99g013.jpg GRAPHIC 121997
16 GRAPHIC aeon-20250520xex99g014.jpg GRAPHIC 149492
  Complete submission text file 0001837607-25-000055.txt   3255239

Data Files

Seq Description Document Type Size
17 EX-101.SCH aeon-20250520.xsd EX-101.SCH 4152
18 EX-101.DEF aeon-20250520_def.xml EX-101.DEF 2869
19 EX-101.LAB aeon-20250520_lab.xml EX-101.LAB 17853
20 EX-101.PRE aeon-20250520_pre.xml EX-101.PRE 10675
30 EXTRACTED XBRL INSTANCE DOCUMENT aeon-20250520x8k_htm.xml XML 5053
Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614
Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499
AEON Biopharma, Inc. (Filer) CIK: 0001837607 (see all company filings)

EIN.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40021 | Film No.: 25968663
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)